The owner of a medical laboratory company in Kenilworth will pay over $13 million in a settlement with the U.S. Attorney’s Office over allegations of illegal kickbacks and medically unnecessary lab tests. Eric Leykin, owner and Chief Executive Officer of RDx Bioscience Inc. in Kenilworth will pay back $10.32 million to the United States and an addition $2.93 million to the state of New Jersey, as well as assist the investigation and litigation against other participants in the alleged scheme, the U.S. Attorney’s Office announced. Leykin, of Brooklyn, New York, was accused by prosecutors of run…